{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T01:11:07Z","timestamp":1773364267971,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.carrev.2019.04.006","type":"journal-article","created":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T19:42:01Z","timestamp":1557344521000},"page":"200-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Role of Genetics in Cardiovascular Risk Reduction: Findings From a Single Lipid Clinic and Review of the Literature"],"prefix":"10.1016","volume":"21","author":[{"given":"Lane B.","family":"Benes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent","family":"Brummell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mendel","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9342-1274","authenticated-orcid":false,"given":"Michael H.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.carrev.2019.04.006_bb0005","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1073\/pnas.71.3.788","article-title":"Familial hyp`ercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity","volume":"71","author":"Brown","year":"1974","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.carrev.2019.04.006_bb0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12944-017-0488-4","article-title":"Genetic determinants of inherited susceptibility to hypercholesterolemia - a comprehensive literature review","volume":"16","author":"Paththinige","year":"2017","journal-title":"Lipids Health Dis"},{"issue":"8","key":"10.1016\/j.carrev.2019.04.006_bb0015","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1161\/ATVBAHA.111.226365","article-title":"An increased burden of common and rare lipid-associated risk alleles contributes to the phenotypic spectrum of hypertriglyceridemia","volume":"31","author":"Johansen","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.carrev.2019.04.006_bb0020","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/CIRCGENETICS.114.000776","article-title":"Exome sequencing in suspected monogenic dyslipidemias","volume":"8","author":"Stitziel","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"issue":"1","key":"10.1016\/j.carrev.2019.04.006_bb0025","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1161\/CIRCGENETICS.111.960864","article-title":"Excess of rare variants in non-genome-wide association study candidate genes in patients with hypertriglyceridemia","volume":"5","author":"Johansen","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"issue":"2","key":"10.1016\/j.carrev.2019.04.006_bb0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/21678707.2018.1419863","article-title":"Advances in diagnosis and potential therapeutic options for familial chylomicronemia syndrome","volume":"6","author":"Benes","year":"2018","journal-title":"Expert Opin Orphan Drugs"},{"issue":"25","key":"10.1016\/j.carrev.2019.04.006_bb0035","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1016\/j.jacc.2016.10.039","article-title":"Genetics: implications for prevention and management of coronary artery disease","volume":"68","author":"Assimes","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.carrev.2019.04.006_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11883-018-0748-4","article-title":"Genome-wide association studies of coronary artery disease: recent progress and challenges ahead","volume":"20","author":"Clarke","year":"2018","journal-title":"Curr Atheroscler Rep"},{"issue":"5","key":"10.1016\/j.carrev.2019.04.006_bb0045","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1161\/CIRCRESAHA.116.302888","article-title":"Are there genetic paths common to obesity, cardiovascular disease outcomes, and cardiovascular risk factors?","volume":"116","author":"Rankinen","year":"2015","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.carrev.2019.04.006_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajhg.2011.11.029","article-title":"Five years of GWAS discovery","volume":"90","author":"Visscher","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.carrev.2019.04.006_bb0055","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fgene.2014.00254","article-title":"Simple, standardized incorporation of genetic risk into non-genetic risk prediction tools for complex traits: coronary heart disease as an example","volume":"5","author":"Goldstein","year":"2014","journal-title":"Front Genet"},{"issue":"7571","key":"10.1016\/j.carrev.2019.04.006_bb0060","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"1000 Genomes Project Consortium","year":"2015","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.carrev.2019.04.006_bb0065","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/ahg.12273","article-title":"Analysis of causal effect of APOA5 variants on premature coronary artery disease","volume":"82","author":"Wang","year":"2018","journal-title":"Ann Hum Genet"},{"issue":"2","key":"10.1016\/j.carrev.2019.04.006_bb0070","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2796.2012.02516.x","article-title":"Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia","volume":"272","author":"Surendran","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.carrev.2019.04.006_bb0075","unstructured":"https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/variation\/200918\/; [accessed 15 December, 2018]."},{"issue":"4","key":"10.1016\/j.carrev.2019.04.006_bb0080","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41431-017-0078-y","article-title":"Usefulness of the genetic risk score to identify phenocopies in families with familial hypercholesterolemia?","volume":"26","author":"Ghaleb","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.carrev.2019.04.006_bb0085","unstructured":"https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/variation\/226329\/; [accessed 15 December, 2018]."},{"key":"10.1016\/j.carrev.2019.04.006_bb0090","unstructured":"https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/variation\/3702\/; [accessed 15 December, 2018]."},{"key":"10.1016\/j.carrev.2019.04.006_bb0095","unstructured":"https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/variation\/3699\/; [accessed 15 December, 2018]."},{"key":"10.1016\/j.carrev.2019.04.006_bb0100","unstructured":"https:\/\/clinvarminer.genetics.utah.edu\/variants-by-submitter\/500031\/condition\/Familial%20hypercholesterolemia\/likely%20pathogenic; [accessed 15 December, 2018]."},{"key":"10.1016\/j.carrev.2019.04.006_bb0105","unstructured":"https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/variation\/226384\/; [accessed 15 December 2018]."},{"issue":"4","key":"10.1016\/j.carrev.2019.04.006_bb0110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/(SICI)1096-8628(19980724)78:4<313::AID-AJMG1>3.0.CO;2-M","article-title":"Ile225Thr loop mutation in the lipoprotein lipase (LPL) gene is a de novo event","volume":"78","author":"Henderson","year":"1998","journal-title":"Am J Med Genet"},{"issue":"2","key":"10.1016\/j.carrev.2019.04.006_bb0115","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jacl.2015.12.015","article-title":"Pathogenic classification of LPL gene variants reported to be associated with LPL deficiency","volume":"10","author":"Rodrigues","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.carrev.2019.04.006_bb0120","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2350-11-66","article-title":"Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study","volume":"11","author":"Ariza","year":"2010","journal-title":"BMC Med Genet"},{"issue":"9","key":"10.1016\/j.carrev.2019.04.006_bb0125","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/jth.13759","article-title":"Characterization of the I4399M variant of apolipoprotein(a): implications for altered prothrombotic properties of lipoprotein(a)","volume":"15","author":"Scipione","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.carrev.2019.04.006_bb0130","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1161\/ATVBAHA.117.309920","article-title":"Lipoprotein(a) and risk of myocardial infarction and death in chronic kidney disease: findings from the CRIC study (chronic renal insufficiency cohort)","volume":"37","author":"Bajaj","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.carrev.2019.04.006_bb0135","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical genetic testing for familial hypercholesterolemia: JACC scientific expert panel","volume":"72","author":"Sturm","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.carrev.2019.04.006_bb0140","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.atherosclerosis.2012.03.024","article-title":"Assessment of the value of a genetic risk score in improving the estimation of coronary risk","volume":"222","author":"Lluis-Ganella","year":"2012","journal-title":"Atherosclerosis"},{"issue":"16","key":"10.1016\/j.carrev.2019.04.006_bb0145","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.jacc.2018.07.079","article-title":"Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention","volume":"72","author":"Inouye","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.carrev.2019.04.006_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2017.03.019","article-title":"Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia","volume":"11","author":"Paquette","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"9984","key":"10.1016\/j.carrev.2019.04.006_bb0155","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/S0140-6736(14)61730-X","article-title":"Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials","volume":"385","author":"Mega","year":"2015","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.carrev.2019.04.006_bb0160","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/CIRCULATIONAHA.116.024436","article-title":"Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting","volume":"135","author":"Natarajan","year":"2017","journal-title":"Circulation"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919302325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919302325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:16:22Z","timestamp":1761560182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838919302325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1553838919302325"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2019.04.006","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Genetics in Cardiovascular Risk Reduction: Findings From a Single Lipid Clinic and Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2019.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}